No Data
SymbolStock Name
PriceChg% ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D % Chg10D % Chg20D % Chg60D % Chg120D % Chg250D % Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
Watchlist
US OptionsDetailed Quotes
RDY250117C17500
- 0.23
- 0.000.00%
15min DelayClose Jan 10 16:00 ET
0.00High0.00Low
0.23Open0.23Pre Close0 Volume20 Open Interest17.50Strike Price0.00Turnover101.86%IV14.98%PremiumJan 17, 2025Expiry Date0.00Intrinsic Value100Multiplier7DDays to Expiry0.23Extrinsic Value100Contract SizeAmericanOptions Type0.2032Delta0.1312Gamma67.04Leverage Ratio-0.0449Theta0.0005Rho13.62Eff Leverage0.0060Vega
Intraday
- 5D
- Daily
News
Top Ranked Indian Equities According to SA Quant
Dr. Reddy's Laboratories' Credit Rating Reaffirmed by ICRA
Dr. Reddy's Laboratories Announces Board Meeting for Financial Results Review
Dr. Reddy's Laboratories Expands European Footprint With New Finnish Subsidiary
Dr. Reddy's Laboratories Forms New Subsidiary In Finland, 'Dr. Reddy's Finland Oy', As Step-Down Wholly-Owned Entity
India's "stock frenzy"? Funds are pouring into the Indian stock market frantically.
In the past five years, India's Nifty 500 Index soared by 126%, far exceeding the performance of the S&P during the same period. An increasing number of Indian retail investors are beginning to believe that Stocks are an "investment that won't incur losses."